Mercer Global Advisors
PRAX icon

Mercer Global Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Mercer Global Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Sell
1,699
-151
-8% -$47.8K ﹤0.01% 2176
2026
Q1 		$596K Buy
1,850
+638
+53% +$197K ﹤0.01% 1868
2025
Q4 		$357K Buy
+1,212
New +$226K ﹤0.01% 2098

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mercer Global Advisors's PRAX Position: Q2 2026 in Review

Mercer Global Advisors reduced its Praxis Precision Medicines (PRAX) stake by 8.2% in Q2 2026, selling an estimated $47.8K and leaving 1,699 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Mercer Global Advisors first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $596K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Mercer Global Advisors held 1,699 shares of Praxis Precision Medicines worth $569K as of Q2 2026.
  • Mercer Global Advisors sold 151 Praxis Precision Medicines shares in Q2 2026, an estimated $47.8K.
  • Praxis Precision Medicines made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2176 holding.
  • Mercer Global Advisors first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • Mercer Global Advisors's Praxis Precision Medicines position peaked at $596K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.